We’ve just published our first October issue and the first issue that deals with the antitrust issues relating to Obama Care. It’s a great issue—check it out:
Healthcare is not only a contentious antitrust issue, but a highly confusing one; we focus here on clinical integration. Christi Braun looks at the challenge of promoting cost-effective health care while controlling joint contracting; Heather Cooper gives some cautionary advice to physicians looking to join forces; Ashley Fischer & David Marx, Jr. analyze antitrust interaction with the new ObamaCare ACOs; Melinda Hatton brings an insider’s viewpoint; Greg Pelnar asks whether physician networks are cartels; and Greg Vistnes advises potential ACOs how to stay safe.
We’ve also added a timely bonus article. Antonio Bavasso & Simon Pritchard discuss how to use the U.K.’s spending review to implement some needed reform in U.K. competition policy; in particular, consolidating the current two-tier system of initial review and full investigation under a single roof.
Clinical Integration: The Balancing of Competition and Health Care Policies
by Christi Braun (Ober Ä°Kaler)
The antitrust agencies are unlikely to challenge a clinical integration network that is able to generate significant efficiencies that benefit consumers and about which payers do not complain.
by Heather Cooper (Sheppard Mullin)
Thanks to a recent federal district court decision, physicians and medical staff have more reason to think twice about price and other arrangements adopted by the practice associations and clinics to which they belong.
by Ashley Fischer & David Marx, Jr. (McDermott Will & Emery)
This article explores how the DOJ and FTC have treated clinically-integrated managed care contracting networks under the antitrust laws, and how the Agencies are likely to apply those concepts to ACOs.
Clinical Integration: Linchpin of Real Reform
by Melinda Hatton (American Hospital Assoc.)
During the year-long debate over health care reform, removing barriers to clinical integration received far less attention than it should have.
Are Clinically Integrated Physician Networks Candy-Coated Cartels?
by Gregory Pelnar (Compass Lexecon)
Are “clinically integrated” physician networks that jointly contract with third-party payors such as Blue Cross little more than “candy-coated” cartels?
by Gregory Vistnes (CRA)
This discussion should help prospective ACOs understand how to pursue the benefits envisioned by the Affordable Care Act while avoiding antitrust concerns.
An Opportunity for Reform of the U.K. Competition Regime
by Antonio Bavasso & Simon Pritchard (Allen & Overy)
There is, however, scope for reform to help the system, as a whole, deliver more for less.
Featured News
Prime Therapeutics Found in Violation of Antitrust Laws, Arbitrator Rules
Jan 23, 2025 by
CPI
Honda and Nissan Face Challenges in China Amid Potential Merger
Jan 23, 2025 by
CPI
Trump Criticizes EU’s Tech Crackdown, Calls It ‘A Form of Taxation’
Jan 23, 2025 by
CPI
Meta Faces Fresh Allegations of EU Law Breaches in Subscription Service Rollout
Jan 23, 2025 by
CPI
European Commission Investigates Crypto Rules for Cross-Border Stablecoins
Jan 23, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – International Criminal Enforcement
Jan 23, 2025 by
CPI
The Antitrust Division’s Recent Work to Combat International Cartels
Jan 23, 2025 by
Emma Burnham & Benjamin Christenson
Information Sharing: The New Frontier of U.S. Antitrust Enforcement
Jan 23, 2025 by
Brian P. Quinn, Casey Kovarik & Michael Tubach
The Key Role of Guidelines on Exchanges of Information Among Competitors and the Divergent Transatlantic Paths
Jan 23, 2025 by
Rosa Abrantes-Metz & Albert Metz
Leniency, Whistleblowers, and Compliance
Jan 23, 2025 by
Richard Powers, Tara O’Malley & Cory Gordon